Lamivudine & Zidovudine Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: Lamivudine 150 mg + Zidovudine 300 mg
Reference Brands: Combivir®(US/ EU)
Category: Anti Viral
Lamivudine & Zidovudine Tablets (150 mg/300 mg) offer a fixed-dose antiretroviral for HIV treatment. Available through PharmaB2B from certified manufacturers, it's ideal for tenders, NGOs, and hospital procurement. Ensure compliant, bulk sourcing from WHO-GMP and USFDA-approved suppliers to support reliable HIV therapy access globally.
Manufacture or export Lamivudine & Zidovudine? List it or send an offer →
Product Description:
Lamivudine & Zidovudine Tablets are a fixed-dose combination of two key NRTIs used in the management of HIV-1 infection. Each tablet contains Lamivudine 150 mg and Zidovudine 300 mg, offering dual-action antiviral activity in a convenient dosing format. Available under brands like Combivir®, this formulation is widely used in global HIV treatment protocols. Through PharmaB2B platforms, healthcare providers and procurement agencies can access bulk supplies from WHO-GMP and USFDA-approved manufacturers. Ideal for tenders, NGOs, and institutional buyers, this ARV combo supports consistent, cost-effective treatment. Connect with trusted suppliers to ensure high-quality antiretrovirals and uninterrupted patient care.
Lamivudine & Zidovudine — third party manufacturing & bulk supply
Lamivudine & Zidovudine is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Lamivudine & Zidovudine is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Lamivudine & Zidovudine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Lamivudine & Zidovudine →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Lamivudine and zidovudine are used together to treat HIV-1 infection. This fixed-dose combination helps reduce viral load, improve immune function, and slow the progression of HIV as part of combination antiretroviral therapy.
It is made from two nucleoside reverse transcriptase inhibitors (NRTIs): lamivudine, a synthetic cytidine analogue, and zidovudine, a thymidine analogue. Together, they block viral replication by inhibiting the HIV reverse transcriptase enzyme.
The most common trade name is Combivir.
Combivir is manufactured by GlaxoSmithKline (GSK) and ViiV Healthcare, with additional production by global generic pharmaceutical companies.
The generic name is lamivudine and zidovudine.
The primary brand name is Combivir.
It is manufactured in approved facilities in the UK, USA, Europe, and India, depending on the manufacturer and regulatory approvals for each region.
Related Products
Efavirenz + Emtricitabine + Tdf
Strength:
600/200/300 mg
Form: Tablet
Reference Brands: Atripla(US/EU)
View DetailsLamivudine
Strength:
Tab:150 mg, 300 mg; Oral solution:10 mg/mL
Form: Tablet & Oral solution
Reference Brands: Epivir®(US/EU)
View DetailsEfavirenz
Strength:
Tab: 200 mg, 600 mg; Cap: 50 mg, 100 mg, 200 mg
Form: Tablet & Capsule
Reference Brands: Sustiva®(US); Stocrin®(EU)
View DetailsNelfinavir Mesylate
Strength:
Tablets: 250 mg, 625 mg: Oral Powder: 50 mg/g
Form: Tablet & Oral Powder
Reference Brands: Viracept®
View DetailsDolutegravir + Abacavir + Lamivudine
Strength:
50 mg / 600 mg / 300 mg
Form: Tablet
Reference Brands: Triumeq(US & EU)
View DetailsDolutegravir + Rilpivirine
Strength:
50 mg / 25 mg
Form: Tablet
Reference Brands: Juluca(EU & US)
View DetailsTenofovir Df + Emtricitabine + Rilpivirine
Strength:
TDF – 300 mg + Emtricitabine – 200 mg + Rilpivirine – 25 mg
Form: Tablet
Reference Brands: Complera(US); Eviplera(EU)
View DetailsTenofovir Df + Emtricitabine + Elvitegravir + Cobicistat
Strength:
Elvitegravir – 150 mg + Cobicistat – 150 mg + Emtricitabine – 200 mg + TDF – 300 mg
Form: Oral tablet (film-coated)
Reference Brands: Stribild (US & EU)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit